	Correction to "Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study". Cancer PMID: 40526083 [PubMed]
	Gilteritinib maintenance after allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute myeloid leukemia with FLT3-internal tandem duplication mutation. Hematology Liang C, Yang D, Pang A, He Y, Zhang R, Zhai W, Feng S, Han M, Chen S, Dou L, Wang Y, Wu X, Jiang E. PMID: 40525981 [PubMed - indexed for MEDLINE]
	Recent advancements in double-expressor lymphoma: novel therapeutic approaches and prospects. Oncologist Zhuo Y, Zhang D. PMID: 40525911 [PubMed - indexed for MEDLINE]
	Current Status of Revisions to the Lugano Classification in Lymphoma. Hematol Oncol Organizing Committee of the Lugano Classification Workshop. PMID: 40525613 [PubMed - indexed for MEDLINE]
	Short-term administration of oclacitinib with concomitant medications in canine epitheliotropic lymphoma: AÂ retrospective study of eight dogs. Vet Dermatol Baba Y, Asakura T, Obayashi S, Yamada M, Otsuka M, Morikawa S, Teh A, Mitsui I, Osumi T. PMID: 40525607 [PubMed - as supplied by publisher]
	Determining treatment pathways for older patients with acute myeloid leukemia: patient and clinician perspectives. Expert Rev Hematol Oliva EN, Almeida A. PMID: 40525509 [PubMed - as supplied by publisher]
	Pulmonary Intravascular Large B-Cell Lymphoma Diagnosed by Transbronchial Lung Cryobiopsy: A Case Report. Respirol Case Rep Wong YS, Furuse H, Matsumoto Y, Sato K, Tsuchida T. PMID: 40524893 [PubMed]
	Simplified Molecular International Prognostic Index as an eligibility criterion for clinical trials: Analysis of the Turkish Lymphoma Study Group's large B-cell lymphoma cohort. Br J Haematol Y, Terzi Demirsoy E, Keklik Karada, Hatipo, Uluköylü Mengüç M, Pekgüç E, Tan T, Nuho, Mastanzade M, Durdu A, Apayd, Özbalak M, Elverdi T, Y, Gören D, Topta, Ula, Mehtap Ö, Dal MS, Akay OM, Ar MC, Saydam G, Altunta, Birta, Ferhano. PMID: 40524448 [PubMed - as supplied by publisher]
	Unveiling the Burden of Leukemia in Eritrea (2010-2020): Chronic Leukemia Stability, Rising ALL Incidence, and the Enigma of CML in a Low-Resource Setting. Cancer Rep (Hoboken) Abraha DM, Mengistu ST, Ghirmay E, Gebresilassie E, Zerat GE, Kokob R, Tesfazghi A, Negash S, Daniel T, Mohammed S, Achila OO. PMID: 40524139 [PubMed - indexed for MEDLINE]
	Flow Cytometric Assessment of TRBC1 Expression for the Diagnosis of T-Cell Lymphoma: Clinical Utility and Pitfalls Related to T-Cell Clones of Uncertain Significance. Int J Lab Hematol Yu S, Kim B, Yoon SE, Kim HJ, Kim HY. PMID: 40521694 [PubMed - as supplied by publisher]
	Gut microbiota is associated with the disease characteristics of patients with newly diagnosed diffuse large B-cell lymphoma. Am J Cancer Res Li Z, Shi J, Wu X, Yan S, Gao Z, Liu Y. PMID: 40520871 [PubMed]
	Immunotherapeutic efficacy of recombinant canine IL-15 as an adjunct to chemotherapy in canine lymphoma. Front Vet Sci Kang MH, Lee J, Kim SK, Koh K, Kang MA, Park HM. PMID: 40520425 [PubMed]
	Immunophenotyping in diagnosing pediatric acute leukemia after setting up the first flow cytometry unit in Mosul City in Iraq: an observational study of the project performed through a contribution from Japan. Transl Pediatr Al-Badrani KS, Al-Kzayer LFY, Ali KH, Khaleel AMA, Fadhil NA, Alsammak BNA, Al-Agele YS, Malallah AH, Abdullah DA, Hamza HH, Kamata M. PMID: 40519741 [PubMed]
	Successful treatment with decompressive laparotomy for abdominal compartment syndrome induced by asparaginase-associated pancreatitis in a pediatric patient with acute lymphoblastic leukemia: a case report. Transl Pediatr Zhang H, Lu W. PMID: 40519724 [PubMed]
	DYRK1A in blood and immune function: implications in leukemia, inflammatory disorders, infection and Down syndrome. Front Cell Dev Biol Rozen EJ, Dowell RD, Allen MA. PMID: 40519271 [PubMed]
	Novel therapies for acute myeloid leukemia. Does age still matter? Blood Rev Krayem B, Frisch A, Horowitz N. PMID: 40518351 [PubMed - as supplied by publisher]
	Comparison of Third-Generation Tyrosine Kinase Inhibitor (TKI) Ponatinib with First- and Second-Generation TKIs for Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: A Systematic Review and Bias-Corrected Meta-analysis. Crit Rev Oncol Hematol Raza MZ, Khwaja HF, Arshad HME, Zulnorain, Maqsood M, Nadeem AA, Omais M. PMID: 40517974 [PubMed - as supplied by publisher]
	Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Update on Biology and Treatment. Hematol Oncol Borchmann P, Eichenauer DA, Frigola G, Campo E. PMID: 40517549 [PubMed - indexed for MEDLINE]
	Marginal Zone Lymphoma: Treatment Update With a Focus on Systemic Approaches. Hematol Oncol Smith SM. PMID: 40517548 [PubMed - indexed for MEDLINE]
	First Line Therapy in Mantle Cell Lymphoma-The Role of BTKi in the Initial Treatment of Transplant-Eligible and -Ineligible Patients. Hematol Oncol Silkenstedt E, Dreyling M. PMID: 40517546 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 159114

Page 1 of 7956



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy